Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer
Arkadiusz Z. Dudek, Timothy Larson, Michael J. McCleod, Daniel J. Schneider, Jonathan E. Dowell, Tarit K. Banerjee, Kishan J. Pandya, Jane L. Bromund, Ruqin Chen, Matthew J. Monberg, Coleman K. Obasaju
Dive into the research topics of 'Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer'. Together they form a unique fingerprint.